Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06405607
PHASE2

Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial

Sponsor: University of Iowa

View on ClinicalTrials.gov

Summary

This study will collect data that measures the effects of a psychedelic intervention on patients struggling with alcohol use disorder (AUD). The study design will be a double blind, randomized, active-comparator trial with two study arms. Subjects randomized to Arm 1 (n=40) will receive individual psychotherapy sessions plus a 30 mg dose of psilocybin. Arm 2 subjects (n=40) will receive individual psychotherapy sessions and a 0.75 mg/kg dose of ketamine.

Official title: Psilocybin vs Ketamine for Alcohol Use Disorder

Key Details

Gender

All

Age Range

21 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2025-06-12

Completion Date

2028-04

Last Updated

2025-11-28

Healthy Volunteers

No

Interventions

DRUG

Psilocybin

30 mg single dose

DRUG

Ketamine

0.75 mg/kg weight-based single dose

Locations (1)

University of Iowa Health Care

Iowa City, Iowa, United States